sidering that estradiol is a major modulator of prolactin (PRL) secretion, the aim of the present study was to analyze the role of membrane estradiol receptor-␣ (mER␣) in the regulatory effect of this hormone on the PRL secretion induced by thyrotropin-releasing hormone (TRH) by focusing on the phosphatidylinositol 3-kinase (PI3K)/ protein kinase B (Akt) pathway activation. Anterior pituitary cell cultures from female rats were treated with 17␤-estradiol (E2, 10 nM) and its membrane-impermeable conjugated estradiol (E2-BSA, 10 nM) alone or coincubated with TRH (10 nM) for 30 min, with PRL levels being determined by RIA. Although E2, E2-BSA, TRH, and E2/TRH differentially increased the PRL secretion, the highest levels were achieved with E2-BSA/TRH. ICI-182,780 did not modify the TRH-induced PRL release but significantly inhibited the PRL secretion promoted by E2 or E2-BSA alone or in coincubation with TRH. The PI3K inhibitors LY-294002 and wortmannin partially inhibited the PRL release induced by E2-BSA, TRH, and E2/TRH and totally inhibited the PRL levels stimulated by E2-BSA/TRH, suggesting that the mER mediated the cooperative effect of E2 on TRH-induced PRL release through the PI3K pathway. Also, the involvement of this kinase was supported by the translocation of its regulatory subunit p85␣ from the cytoplasm to the plasma membrane in the lactotroph cells treated with E2-BSA and TRH alone or in coincubation. A significant increase of phosphorylated Akt was induced by E2-BSA/ TRH. Finally, the changes of ER␣ expression in the plasmalemma of pituitary cells were examined by confocal microscopy and flow cytometry, which revealed that the mobilization of intracellular ER␣ to the plasma membrane of lactotroph cells was only induced by E 2. These finding showed that E2 may act as a modulator of the secretory response of lactotrophs induced by TRH through mER, with the contribution by PI3K/Akt pathway activation providing a new insight into the mechanisms underlying the nongenomic action of E2 in the pituitary. lactotrophs; thyrotropin-releasing hormone ESTROGEN ACTS AS AN IMPORTANT MODULATOR of many lactotroph functions, including the synthesis and secretion of prolactin (PRL), cell proliferation, and apoptosis (44, 46) . In addition, estrogen sensitizes lactotrophs to respond to neuropeptides and to growth factors by inducing differential secretory activity (10, 40) and stimulating PRL cell proliferation (11, 22) , respectively.
and stimulating PRL cell proliferation (11, 22) , respectively.
The biological actions of estradiol are classically mediated through the estrogen receptors (ER) ␣ or ␤, which function as ligand-dependent transcription factors, with both isoforms being localized in different pituitary cell types (32) . The presence of the classical ␣ and ␤ ERs and the signaling pathways involved in estrogen regulation of hormone secretion, cell proliferation, and cell death have been reported in pituitary gland (47) . In addition to cytoplasmic/nuclear localization of ER, in several cell types there are also small pools of ER␣ and -␤ at the plasma membrane (mER) (28, 34) that can be activated and rapidly trigger multiple signal transduction cascades through direct interactions of ER with various proteins, including growth factor-dependent kinases and adaptor proteins (30, 43) . This multiprotein complex leads to the activation of many downstream signaling molecules, such as protein kinase C (PKC) (38) , protein kinase A (3) , nitric oxide (NO) (24) , mitogen-activated protein kinase (5), phosphatidylinositol 3-kinase (PI3K)-protein kinase B (Akt) (12) , and increased calcium levels in different tissues (6) . It has been reported that, in the presence of estradiol, ER␣ interacts with the p85␣ regulatory subunit of PI3K, thus triggering activation of the p110 catalytic subunit, increasing intracellular production of phosphoinositides and leading to Akt activation (8) .
In previous studies, we demonstrated the participation of the membrane-bound ER in the regulatory action of 17␤-estradiol (E 2 ) on the secretory and proliferative lactotroph cell activities from primary pituitary cell cultures. Estradiol through membrane ER reversed the proliferative effect of insulin by inhibition of the PKC⑀/extracellular signal-regulated kinase (ERK) 1/2/Pit-1 cascade and stimulation of the NO/soluble guanylate cyclase/cGMP signaling pathway (19, 20) . Moreover, we showed the presence of mER␣ in pituitary cells, specifically in lactotrophs, which mediated the PRL secretion stimulated by E 2 through PKCs/ERK1/2 activation (19) . Related to this, nongenomic effects of E 2 on PRL secretion were previously reported in normal pituitary tissue (9) and GH3/B6 cells, with the effects of E 2 on PRL release being described to be dependent on the mER␣ levels (6) .
Another report described that the PI3K/Akt pathway regulated PRL secretion by an ERK-dependent mechanism in insulin-like growth factor (IGF)-I-stimulated pituitary cells (37) . However, to date, the participation of the PI3K/Akt pathway in membrane-initiated estrogen actions on the regulation of PRL release has been little explored.
The control of PRL secretion involves a complex interrelationship between neurohormones, neurotransmitters, and the plasmatic levels of ovarian steroids. PRL is tonically inhibited by dopamine, the main PRL-inhibiting factor, and can be stimulated by a number of neuropeptides, with thyrotropinreleasing hormone (TRH) being the principal physiological factor stimulating the fast release of PRL (16) .
In female rats, PRL secretion shows marked changes in different reproductive states, such as the estrous cycle (39), pregnancy (1), and lactation (42) . During the estrous cycle, the serum PRL levels fluctuate, reaching a peak on the proestrous afternoon depending on the increase in the plasma estradiol levels (33) , which is coincident with the highest ER␣ expression at proestrus (17) . This event is associated with a significant TRH release into hypophysial portal blood (14, 15) and plays an important role in the timing and initiation of the PRL surge in the proestrous (23) .
The stimulatory effects of estrogens are exerted at the hypothalamic level, thereby eliciting the release and activity of stimulatory hypophysiotropic factors such as TRH (31) and at the pituitary level by increasing the transcription rate of the PRL gene (25) . Furthermore, in lactotroph cells, it has been demonstrated that E 2 upregulates the mRNA expression levels of the TRH receptor by an increase in both the transcription rate and stability of this receptor (27) , thus modulating the fast actions of TRH on PRL secretion.
Bearing in mind that E 2 participates as the main modulator of the secretory response of lactotroph cells to TRH, it is of great interest to analyze the contribution of membrane-associated ER␣ by focusing on the PI3K/Akt pathway activation in this effect. A better knowledge of the molecular mechanisms involved could contribute to understand how rapid changes in PRL levels occur in different physiological processes.
MATERIALS AND METHODS
Reagents and antibodies. E2, 17␤-estradiol 6-O-carboxymethyloxime-BSA (E2-BSA), TRH, ICI-182,780, wortmannin, and LY-294,002 were purchased from Sigma-Aldrich (St. Louis, MO). Antibodies recognizing ER␣ MC-20 (directed to the COOH-terminal of the ER␣), total Akt1/2, phosphorylated Akt1/2/3 (Ser 473 ), and the PI3K-p85␣ subunit were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). Rabbit polyclonal anti-PRL was provided by Dr. A. Parlow (National Hormone and Pituitary Program, Torrance, CA). The ␤-actin mouse monoclonal antibody was obtained from SigmaAldrich.
Animals. Three-month-old female virgin rats of the Wistar strain were used. Large pools of these animals were assigned to each culture taken at random cycle stages (n ϭ 25-30). All rats were bred and housed at the Animal Research Facility of the National University of Córdoba, under controlled temperature (21 Ϯ 3°C) and lighting (14:10-h light-dark cycle) conditions, having free access to commercial rodent food and tap water. Animals were kept in accordance with the Guide for the Care and Use of Laboratory Animals, published by the United States National Institutes of Health (1996) , and the experiments were approved by the local Institutional Animal Care Committee.
Anterior pituitary cell culture. The rats were decapitated within 10 s of removal from their cage, thus avoiding any stress or external stimuli. The protocol for the dissociation of pituitary cells has been described previously (10) . Briefly, anterior pituitaries excised from female rats were placed in minimal essential medium for suspension culture, before being minced, digested with 0.4% trypsin, and dispersed with Pasteur pipettes. The cell yield was 1.5-2 ϫ 10 6 /pituitary, and the cell viability, tested with Trypan blue exclusion, was always better than 90%. The final suspension was adjusted to 1 ϫ 10 6 cells/ml of medium. For PRL secretion analysis and the other techniques, the cells were plated on six-well culture plates (Corning) at a density of 7 ϫ 10 5 cells/well. For immunofluorescence by Confocal Laser Scanning Microscopy, the cells were seeded on glass cover slips (13 mm) at a density of 1.5 ϫ 10 5 cells/well on 24-well culture plates (Corning). Next, the cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 4% FCS and 8% horse serum (GIBCO) in an oven with a humidified atmosphere of 5% CO 2 and 95% air at 37°C for 3 days.
All culture media were filtered through 0.2-m Nalgene membranes (Nalge). The cell culture grade reagents were obtained from Sigma Chemical.
Cell treatment conditions and use of inhibitors. After 3 days of culture, the cells were maintained in DMEM without Phenol Red and serum supplemented with hydrocortisone (100 g/l), 3,3=-triiodothyronine (400 ng/l), transferrin (10 mg/l), and sodium selenite (5 g/l) for 24 h before treatments. Next, the cells were stimulated for 30 min with vehicle (0.1% BSA), E 2 (10 nM), E2-BSA (10 nM), and TRH (10 nM), either alone or in combination. In addition, pituitary cells were preincubated with a range of concentrations of the competitive inhibitor of E 2 binding ICI-182,780 (100, 500, or 1,000 nM) and with specific PI3K inhibitors: LY-294002 (10 M) and wortmaninn (100 nM). These inhibitors were applied for 30 min before the stimulation with E2, E2-BSA, and TRH alone or in combination for another 30 min. The culture media were collected and stored frozen at Ϫ20°C before determining the PRL levels by radioimmunoassay. The anterior pituitary cells were processed to confocal laser scanning microscopy, Western blot, and flow cytometry.
A stock solution of E2-BSA was made according to our previous report (19) , by dissolving the powder in buffer (50 mM Tris·HCl, pH 8.5) at 1 mg/ml. An aliquot of the solution was added to a centrifugal filter unit with a molecular weight cutoff of 3,000 (Millipore) and subjected to centrifugation at 13,000 g for 30 min. The filtrate was recovered, and the retentate was washed three times with 400 l of Tris·HCl buffer.
PRL determination. The PRL concentration in the culture medium was measured by a double-antibody radioimmunoassay (RIA), with materials supplied by Dr. A. F. Parlow from the National Hormone and Pituitary Program. The PRL was radioiodinated using the chloramine T method and purified by passage through Sephadex G-75 and polyacrylamide agarose (ACA 54; LKB, Bromma, Sweden) columns. The assay sensitivity was 1 ng/ml medium, and the inter-and intra-assay coefficients of variation were Ͻ10%.
Confocal laser scanning microscopy. Cover slips containing attached pituitary cells from different experimental groups were fixed with 4% formaldehyde, permeabilized with 0.25% Triton X-100 in PBS, and incubated for 1 h with 5% PBS-BSA to block nonspecific binding. Slides were incubated overnight with ER␣ rabbit polyclonal antibody (1:50) in a humidified chamber at 4°C, which were then washed three times with PBS and further incubated with Alexa 594 antirabbit secondary antibody (1:1,000; Invitrogen) for 1 h. Concanavalin A Alexa Fluor 488 conjugate (100 g/ml; Invitrogen, Eugene, OR), a lectin that specifically binds to the ␣-mannosyl saccharides expressed in the core structures of plasma membrane glycoproteins, was used as a plasma membrane marker.
For double inmunostaining, slides were incubated for 1 h with anti-p85␣ (1:50 rabbit polyclonal), followed by 1 h with Alexa 594 antirabbit as the secondary antibody, before being washed and then incubated with anti-PRL antibody using fluorescein isothiocyanate (FITC) antirabbit as the secondary antibody (Santa Cruz Biotechnology), as explained above.
To validate the specificity of the immunostaining, controls were performed by applying the same protocol but replacing primary antibody with 1% PBS-BSA.
Images were then obtained using an inverted confocal laser scanning microscope (FluoView FV 1,000; Olympus, Tokyo, Japan). An Ar-ion 488-nm laser was used for excitation of green fluorescence and a 543-nm one for excitation of red fluorescence. Serial z-axis sections were collected using a ϫ60 or ϫ100 objective. An analysis of the confocal microscopy images was performed using the software FV10-ASW 1.6 Viewer.
Preparation of cell lysates for Western blot analysis. Once the experimental protocols were completed, the pituitary cells were rinsed with PBS and lysed on ice by the addition of 120 l of cold PBS containing 1.25% Igepal CA-630, 1 mM EDTA, 2 mM phenylmethylsulfonyl fluoride, 10 g/ml leupeptin, and 10 g/ml aprotinin. This was followed by the scraping and transfer of the lysate to a centrifuge tube placed on ice. After 30 min, these lysates were centrifuged at 13,000 rpm for 20 min at 4°C, and the supernatants were collected and stored in aliquots frozen at Ϫ40°C until required.
The protein concentration of the cell lysates was determined using the Bio-Rad Protein Assay (Bio-Rad Laboratories, Hercules, CA).
Fifty micrograms of total homogenate were separated using 12% acrylamide gel (Sigma Chemical), and, to estimate the corresponding molecular weights, the Full Range Rainbow Molecular Weight Marker was run in parallel (Amersham-Life Science, Bucks, UK). The proteins were transferred to the nitrocellulose membrane, and nonspecific binding was blocked with PBS containing 5% nonfat dried milk and 0.1% Tween 20 (blocking buffer) at room temperature. The membranes were rinsed and incubated for 2 h with the appropriate primary antibodies rabbit polyclonal antitotal Akt1/2 (1:300) and antiphosphorylated Akt1/2/3 (Ser 473 ; 1:300). The blots were incubated with a peroxidase-conjugated (HRP) antirabbit secondary antibody (1:5,000; Jackson Immunoresearch Laboratories, West Grove, PA) diluted in blocking buffer and then thoroughly rinsed in PBS/ 0.1% Tween 20, and the HRP-coupled secondary antibody was revealed with enhanced chemiluminescence Western blot detection reagents (Inmuno Star HRP Substrate Kits; Bio-Rad Laboratories) following the manufacturer's instructions. Emitted light was captured on Hyperfilm (Amersham-Pharmacia-Biotech, Bucks, UK), and signals were scanned and quantified with Scion Image software (version beta 4.0.2; Scion Image, Frederick, MD) at three different exposure times. The expression of ␤-actin (1:5,000) was used as an internal control to confirm an equivalent total protein loading.
Flow cytometry. Living dispersed cells were incubated with anti-ER␣ (1:50) or an appropriate isotype control (BD Biosciences) for 30 min at 4°C and then incubated with secondary antibody Alexa Fluor 647 (1:1,000; Invitrogen) for 30 min at 4°C. Next, the cells were fixed (CITOFIX; BD Biosciences Pharmingen, San Diego, CA) for 20 min at 4°C and permeabilized with Perm/Wash (BD Biosciences Pharmiogen), before being incubated with primary antibody (1:20,000, anti-PRL) for 30 min at 4°C followed by incubation with secondary FITC antibody (1:300; Santa Cruz Biotechnology) for 30 min at 4°C. As isotype control, the cells were incubated with rabbit normal serum instead of PRL or ER␣ antibody. Finally, the cells were washed, resuspended in filtered PBS, and analyzed by flow cytometry (1 ϫ 10 5 Fig. 1 . Effect of 17␤-estradiol (E2) and thyrotropin-releasing hormone (TRH) combined treatments on prolactin (PRL) secretion. The presence of E2 (10 nM), 17␤-estradiol 6-O-carboxymethyloxime-BSA (E2-BSA) (10 nM), or TRH (10 nM) alone or in combination for 30 min induced a significant increase in the PRL release, attaining the highest values after E2-BSA/TRH treatment. Results are given as means Ϯ SE of 6 wells from three independent experiments, and data were evaluated by the ANOVA followed by Tukey's posttest: **P Ͻ 0.01 vs. control;^P Ͻ0.05 vs. E2; and ##P Ͻ0.01 vs. TRH. Fig. 2 . Effect of ICI-182,780 (100 nM) on PRL secretion induced by E2 and TRH combined treatment in pituitary cell cultures. The specific antagonist of estrogen receptors (ERs) reversed the PRL release induced by E2 (10 nM) or E2-BSA (10 nM) alone or in coincubation with TRH (10 nM) and was unable to modify the rise in PRL levels promoted by TRH. The data are expressed as means Ϯ SE of 6 wells from three independent experiments, and data were evaluated by the ANOVA followed by Tukey's posttest: *P Ͻ0.05 vs. E2 or E2-BSA and **P Ͻ0.01 vs. E2/TRH or E2-BSA/TRH. events/experimental treatment; Ortho Diagnostic System, Raritan, NJ). A data analysis was carried out using the FlowJo software (Tree Star, Ashland, OR), the percentage of mER␣-positive lactotrophs was calculated by the equation [(mER␣ ϩ PRL ϩ )/total PRL ϩ cells] ϫ 100, and the variations of intensity levels of mER␣ were determined using the geometric mean fluorescence intensity.
Statistical analysis. The statistical analysis was carried out on three replicates measured on three independent cell cultures using an ANOVA with Tukey's posttest (InfoStat software package). Significance levels were chosen at P Ͻ 0.05.
RESULTS

E 2 acting through membrane-associated ER increased the PRL release induced by TRH.
We investigated whether E 2 was able to modulate the PRL release induced by TRH and, if so, the involvement of the membrane-associated ER in this effect. Primary cell cultures were incubated with E 2 , E 2 -BSA (E 2 covalently linked to membrane-impermeable BSA), or TRH alone or using a combination of the neuropeptide with E 2 or E 2 -BSA. As shown in Fig. 1 , E 2 stimuli caused a significant Fig. 4 . Translocation of p85␣ regulatory subunit of PI3K to the plasma membrane of lactotroph cells. Pituitary cell cultures, nonstimulated or stimulated with E2, E2-BSA, and TRH alone or combination for 30 min, were immunolabeled for p85␣ (red) and PRL (green). A notable p85␣ translocation from the cytoplasm to the plasma membrane (arrows) of lactotroph cells (merge) was observed when the cells were exposed to TRH alone or in coincubation with E2 or E2-BSA. The images correspond to a representative experiment from a total of three with similar results. Bar ϭ 10 m.
increase of around 120% in the PRL levels, with E 2 -BSA incubation inducing an even greater effect and reaching values of 180% compared with nonstimulated cells. As was expected, a noticeable PRL secretion of about 300% was observed when the pituitary cells were treated with TRH. Moreover, the highest PRL levels in culture media were quantified after E 2 -BSA/TRH incubation, reaching values of 500% compared with control and with approximately a 60% increase with respect to the levels promoted by TRH. These results suggest that E 2 acting through membrane ER may have exerted a cooperative effect with TRH to promote PRL release.
To examine the specificity of estrogen action on PRL secretion, we studied the effect of ICI-182,780, the pure antagonist of the ER. Pituitary cells were preincubated using a range of ICI concentrations (100, 500, and 1,000 nM) for 30 min before exposition to specific factors for an additional 30 min (data not shown). For all pretreatments, ICI significantly inhibited the PRL secretion promoted by E 2 or E 2 -BSA. Next, based on the responses obtained and those from previous work (21) , in this study we selected the lower dose (100 nM), which reduced the PRL secretion induced by TRH coincubated with E 2 or E 2 -BSA. As was expected, ICI did not modify the PRL release induced by TRH (Fig. 2) .
PI3K participated in the stimulatory effect induced by E 2 and TRH on PRL secretion.
To analyze whether PI3K was involved in the secretory activity of lactotroph cells induced by E 2 or E 2 -BSA coincubated with TRH in lactotroph cells, the two PI3K inhibitors LY-294,002 and wortmannin were used. The preincubation of pituitary cells with LY-294,002 (10 M) or with wortmannin (100 nM) did not modify the PRL secretion induced by E 2 . However, when the pituitary cells were preincubated with PI3K inhibitors before the addition of E 2 -BSA, TRH, or E 2 /TRH, the PRL release was partially blocked. Furthermore, both inhibitors were able to block completely the secretory activity of lactotroph cells promoted by E 2 -BSA/ TRH, reaching levels similar to control (Fig. 3) . These results suggest that the ER membrane mediated the cooperative effect of E 2 on TRH-induced PRL release through the PI3K pathway. E 2 -BSA/TRH induced both p85␣ translocation at the membrane in lactotroph cells and Akt phosphorylation. To evaluate the activation of PI3K induced by E 2 , E 2 -BSA, and TRH, we analyzed the translocation of the PI3K regulatory subunit p85␣ in lactotroph cells by confocal laser scanning. In unstimulated PRL cells, the immunofluorescence corresponding to the p85␣ subunit was mainly observed in the cytoplasm compartment, which could have been indicative of an inactive state. E 2 -BSA and TRH alone or in coincubation induced translocation of the p85␣ subunit from the cytoplasm to the plasma membrane of the lactotroph cells, which may be interpreted as a hallmark of activation. On the other hand, free E 2 was unable to modify the subcellular distribution of this subunit, although, when coincubated with TRH, p85␣ mobilization to the plasma membrane was detected (Fig. 4) .
In addition, we analyzed the Akt expression, considered to be the principal downstream kinase of the PI3K pathway. The total and phosphorylated Akt were detected by immunoblotting using specific antibodies as bands of ϳ56 kDa. As shown in Fig. 5 , the incubation of E 2 -BSA/TRH for 30 min in serum-free culture medium induced a significant increase of phosphorylated Akt compared with respective control. Total Akt expression was similar for all lines. The expression of ␤-actin was used as an internal control to confirm equivalent total protein loading.
In summary, both p85␣ translocation to the plasma membrane of the lactotrophs and Akt phosphorylation might indicate activation of the PI3K pathway in response to E 2 -BSA/ TRH stimuli, leading to the highest PRL release.
ER␣ translocation to the plasma membrane in pituitary cells was induced by E 2 . Considering that the ER membrane participated in the regulatory effects of E 2 on the PRL secretion induced by TRH, we analyzed the changes of ER␣ expression in the plasma membrane of pituitary cells after E 2 /TRH stimuli by confocal microscopy and flow cytometry. In unstimulated pituitary cells, the endogenous ER␣ specific immunostaining was mainly observed in the nucleus and cytoplasm by confocal microscopy. However, E 2 and E 2 /TRH treatment for 30 min increased ER␣ expression at the plasma membrane of pituitary cells besides the cytoplasmic and nuclear localizations (Fig. 6A) .
The presence of ER␣ within the plasma membrane was confirmed using Alexa 488-labeled concanavalin A, a lectin that specifically binds to ␣-manosyl saccharides expressed in the core structures of plasma membrane glycoproteins. ER␣ and concanavalin A colocalization at the membrane plasmatic level was observed after E 2 /TRH stimulation for 30 min (Fig. 6B) .
To evaluate the changes in the ER␣ expression on the surface of lactotroph cells induced by E 2 , E 2 -BSA, and TRH alone or in combination, a flow cytometry analysis was carried out. Figure 7A shows that ϳ69% of all scanned cells were lactotrophs identified using a PRL antibody, with simultaneous labeling with a specific ER␣ antibody indicating that 6.1 Ϯ 0.6% of these cells also expressed ER␣ at the cell surface. Moreover, this percentage did not change for any condition tested. Although the ER␣ basal expression at the cell surface did not alter after TRH, E 2 -BSA, or E 2 -BSA/TRH stimuli, the E 2 and E 2 /TRH treatments for 30 min induced a significant increase in the geometrical mean of ER␣ ϩ Fig. 5 . Western blot analysis of protein kinase B (Akt) expression from total pituitary cell extracts. E2-BSA/TRH stimuli for 30 min induced a significant increase of phosphorylated Akt (p-Akt, Ser 473 ) expression. The total Akt (T-Akt) signals were similar for all lines, and ␤-actin expression was used to confirm equivalent total protein loading. A representative panel of three independent experiments is shown. The graph represents the p-Akt-to-T-Akt ratio of the means Ϯ SE of three independent experiments, and the data were evaluated by the ANOVA followed by Tukey's posttest: **P Ͻ 0.01 vs. C and^P Ͻ 0.01 vs. TRH.
fluorescence intensity on the surface of lactotroph cells compared with the basal state (P Ͻ 0.01; Fig. 7B ). No significant differences in mER␣ expression between the E 2 and E 2 /TRH treatments were detected. These data indicate that the mobilization of intracellular ER to the plasma membrane of lactotroph cells was only induced by E 2 .
DISCUSSION
It is well known that estrogen acts as an important modulator of the neuroendocrine signals that classically regulate the PRL secretion by a transcription-dependent mechanism (2, 16). However, since the participation of different ER pools and the signaling pathways involved in this effect have not been fully elucidated, we investigated the role played by mER in the modulatory effect of E 2 on PRL secretion in response to TRH in primary cultures of female rat anterior pituitary cells. It was found that the incubation with E 2 , E 2 -BSA, and TRH differentially increased PRL secretion in a rapid fashion, attaining the highest levels after E 2 -BSA/TRH stimuli. Steroids conjugated to BSA have been shown to be impermeant to the plasma membrane and therefore cannot access the cytoplasmic receptors. Accordingly, they have been used increasingly as tools to investigate nongenomic, cell-surface steroid effects (41) . In this study, the PRL-secretagogue actions of E 2 -BSA and E 2 -BSA/TRH strongly suggest an effect on the membrane E 2 -binding sites. In a previous work, the rapid PRL-secretagogue effect of estrogens mediated by mER was achieved independently of DNA transcription and did not seem to involve a nuclear receptor (9) .
The PRL release induced by E 2 -BSA was significantly higher than that of free E 2 , inferring the possibility that this effect may have originated because the conjugated steroid persistently stimulated the mER for 30 min. Free E 2 also binds to mER but readily diffuses inside the cells after application and activates the intracellular receptors. These data are in agreement with our previous report (19) and also with Bulayeva and coworkers (6) , who demonstrated the more pronounced Ca 2ϩ elevation and PRL secretion caused by E 2 -BSA compared with free estradiol in pituitary cell lines. Although no effect of free E 2 on TRH-induced PRL release was detected for our experimental conditions, the ICI-182,780 pretreatment resulted in a reduction of the PRL secretory levels induced by both factors, suggesting the ER participation in the E 2 effect on TRH-promoted PRL secretion. One possible explanation could be that the rapid stimulation of the mER induced by free E 2 may be overlapped or hidden by the powerful secretory stimulus exerted by TRH. Therefore, the contribution of mER in the cooperative effect of E 2 -BSA/TRH was confirmed by the significant reduction of PRL secretion promoted by ICI-182,780 pretreatment.
In an attempt to achieve a better understanding of the signaling pathway underlying the effects of E 2 modulating the TRH-induced PRL secretion, we analyzed the participation of the PI3K/Akt pathway. Our results showed that the PI3K inhibitors were unable to modify the PRL secretion stimulated by E 2 , suggesting the contribution of other signaling cascades in the estradiol action on lactotroph secretory activity. In fact, in a previous work, we showed the activation of the PKC signaling pathway through mER␣ in PRL release from lactotroph cells (19) . Furthermore, the activation of cAMP (26) , ERK phosphorylation (5), and/or increased intracellular calcium (6, 45) has been demonstrated to be involved in regulation of PRL release.
In the present study, we observed that the E 2 -the BSAstimulated PRL release was partially inhibited by LY-294,002 and wortmannin, indicating that PI3K participated in this effect. Although it is believed that free E 2 through mER activates PI3K in a similar manner to E 2 -BSA, in our experiments E 2 failed to exert this action. We hypothesize that a sustained stimulation of mER by E 2 -BSA might be required for the PI3K activation under our experiment conditions. Also, the participation of PI3K in the E 2 -and BSA-induced PRL release is strongly suggested by the translocation of its regulatory subunit p85␣ from the cytoplasm to the plasma membrane in the lactotroph cells, which is indicative of PI3K activation. Moreover, the total blockade exercised by LY-294,002 and wortmannin on the PRL secretion promoted by E 2 -BSA/TRH suggests that mER activation may potentiate the TRH effect on PRL release through the PI3K pathway. This interpretation has also been suggested for other molecules in neurons, which, acting through their membrane receptors, were able to amplify the TRH effect by positive modulation of its transduction mechanism (35, 36) .
To analyze further the contribution of the PI3K/Akt pathway, we examined the phosphorylation of the principal kinase Akt, downstream of the PI3K. Under our experimental conditions, when cells were treated with E 2 -BSA or TRH, no significant increase of phosphorylated Akt expression was detected by Western blot. However, the E 2 -BSA/TRH treatment induced a strong Akt phosphorylation, suggesting that the PI3K/Akt pathway was involved in the effect of both secretagoges on the PRL release. In agreement, estradiol in interaction with IGF-I increased the Akt phosphorylation in the brain, including the hippocampus, the cerebral cortex, hypothalamus, and the cerebellum (7).
The present study demonstrates for the first time that mER mediate the cooperative effect exerted by E 2 on rapid PRL release induced by TRH through the activation of PI3K/Akt, a convergent signaling pathway involved in this regulatory effect. In a physiological environment, there is a basal level of estrogen that fluctuates under different reproductive states. This variation may in turn activate the mER-triggering effects mediated in part by PI3K activation as observed with E 2 -BSA in our experimental conditions.
Having demonstrated that mER play a central role in modulating the effect of E 2 on TRH-induced PRL secretion, we next focused on the analysis of the changes in mER␣ expression in pituitary cells after stimulation with E 2 , E 2 -BSA, and TRH alone or in combination using confocal microscopy and flow cytometry. Our findings showed that the increased ER␣ expression observed at the plasma membrane of pituitary cells, specifically on the surface of lactotroph cells after E 2 and E 2 /TRH incubation, was due to intracellular ER␣ translocation to the plasma membrane induced by E 2 . The similar rise in mER␣ expression detected for both E 2 and E 2 /TRH allows us to infer that TRH did not cause ER␣ mobilization. Furthermore, the ER␣ basal expression at the cell surface did not alter following E 2 -BSA stimuli, which allows us to infer that the resident pool of membrane ER␣ (stimulated steadily) could have been responsible for PRL release in experiments where E 2 -BSA was added. In accordance with our results, other reports have demonstrated that E 2 regulates the endogenous ER translocation to the plasma membrane in Sertoli cells (29) , hypothalamic cells (13) , neurons (18) , astrocytes (4), and pituitary cells (21) .
In the present study, the fact that the increase in mER␣ expression detected in lactotroph cells after E 2 /TRH treatment correlated with the highest PRL secretion observed after E 2 -BSA/TRH stimuli could be a clear indicator of the role that the membrane ER␣ plays in mediating the cooperative effect of E 2 on the rapid PRL release induced by TRH.
In summary, our results show that estradiol may act as a modulator of the secretory response of lactotrophs induced by TRH through membrane ER, with this contribution being provided by PI3K/Akt pathway activation. It is also possible that this mechanism is implicated in the enhancement of the PRL levels observed in different reproductive states, such as the estrous cycle, pregnancy, and lactation, which are closely associated with fluctuations in the estrogen and TRH levels, thus revealing a new insight into the mechanisms underlying the nongenomic action of E 2 in the pituitary glands.
